Rs4986782

NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma.


 * is_associated_with_disease::Urinary bladder cancer
 * is_associated_with_disease::Non-Hodgkin lymphoma